The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...